Cites

Cites Startups 2014 Center for Technological Innovation and Social Enterprise, a startup Sancor Insurance Group created to support innovation. They want to generate a cluster of technology companies and exercise role linker between research sectors, production, business and social. They do this by providing an interdisciplinary support between technology and business, with the aim of strengthening the scientific, economic and social development of the region and country areas.

Nicolas Tognalli Ph.D

Managing Partner

17 past transactions

Teramot

Seed Round in 2024
Teramot develops AI software that enables businesses to swiftly access and comprehend their data, enhancing decision-making processes with minimal effort.

NeuroAcoustics

Seed Round in 2024
NeuroAcoustics is a company focused on addressing neurological conditions through innovative technology that manages brain waves during sleep. It designs user-friendly at-home devices aimed at enhancing cognitive function for both healthy older adults and those with mild cognitive impairment. By offering personalized solutions, NeuroAcoustics seeks to improve cognitive states and sleep quality, catering to individuals in need of supportive tools for their neurological health.

Ergo Bioscience

Seed Round in 2023
Ergo Bioscience is a biotechnology company specializing in the precise fermentation of plant cells to produce animal proteins. Its mission is to innovate and provide environmentally friendly solutions for the food sector, focusing on flavors, aroma, color, and texture found in animal-derived products.

Epiliquid

Seed Round in 2023
Epiliquid develops a platform that uses biomarkers detected in liquid biopsies to enable early cancer detection. The approach supports non-invasive screening, aids diagnosis and monitoring, and enables personalized medicine by guiding treatment decisions based on biomarker signals, with the goal of improving survival outcomes.

Selectivity Life

Seed Round in 2023
Selectivity Life is a healthcare company which develops reproductive medical devices which bring fertility treatments to patients' homes.

Limay Biosciences

Seed Round in 2022
Limay Biosciences develops innovative biotechnology solutions for molecular testing. Their platform enables real-time decision-making on food quality and health by offering simple, precise, and low-cost testing tools.

Stradot

Seed Round in 2021
Stradot specializes in developing high-speed, eco-friendly parking systems aimed at optimizing urban space. The company has created an autonomous robotic system that enhances the capacity of existing parking facilities by increasing operational efficiency. This innovative technology allows for the densification of surface parking without the need for permanent infrastructure, enabling clients to recover up to half of the space in their parking lots while accommodating a greater number of vehicles. Stradot’s solutions address the challenges of crowded urban environments by providing cost-effective and sustainable parking options.

CRINSURANCE

Seed Round in 2021
CRINSURANCE develops a preservation system for eggs, sperm, and embryos used in fertility labs. Its solutions include a cryotank that securely stores embryos and tracks them digitally, improving workflow and traceability for IVF centers; the system stores embryos and gametes in liquid nitrogen with no routine refills, offering a more reliable alternative to traditional cryobanks and supporting fertility outcomes.

ViewMind

Seed Round in 2020
ViewMind is a digital health company specializing in AI-powered neurocognitive assessments. It uses eye movement monitoring to detect and track Alzheimer's disease and other neurological conditions, providing accurate brain health data.

Eolo Pharma

Series A in 2020
Eolo Pharma is a pharmaceutical company dedicated to researching and developing molecular drugs aimed at treating chronic inflammation and its related diseases. Its primary focus lies in creating targeted small-molecule therapies, including thermogenic compounds like MVD1, to manage obesity, type 2 diabetes, and neurodegenerative disorders more effectively.

RadBio

Seed Round in 2020
RadBio is a biotechnology company focused on developing innovative therapies for fibrotic disorders and solid tumors. The company has created a therapeutic platform centered around an Fc-fusion protein designed to neutralize excess levels of TGF-β, a key factor involved in fibrosis and tumor progression. This approach aims to address unmet medical needs in the treatment of various fibrotic conditions and cancers by selectively targeting the problematic aspects of TGF-β without disrupting its essential signaling pathways. RadBio is exploring multiple indications where their biomolecule may have significant therapeutic potential.

Bionirs

Seed Round in 2020
Bionirs is a company focused on advancing light-based biomedicine technology to enhance the quality of life. It has developed an innovative optical system called MamoRef, which offers a non-invasive approach to mammography. This device utilizes infrared light to create a medical imaging system that allows for simple, affordable, and painless mammograms. By leveraging this technology, Bionirs aims to improve access to essential health screenings for patients, making the process more comfortable and cost-effective.

ARDAN PHARMA

Seed Round in 2019
ARDAN Pharma is a biotechnology company focused on discovering and developing novel oncology drugs. With over a decade of research into immune system modulation, the company's portfolio comprises potential new drugs with synergistic effects when used alongside immunotherapies and Bcl-2 antagonists. ARDAN Pharma aims to transform cancer treatment by developing and validating first-in-class compounds targeting emerging molecular pathways.

GBOT

Pre Seed Round in 2019
GBOT is a robotics company that develops an autonomous ground platform to control weeds without agrochemicals and to phenotype plants in experimental plots. Its system gathers high-quality, in-situ data with IoT-enabled sensors, enabling breeders to describe each plant in detail and make better cultivar selections. By combining autonomous robotics with field data, GBOT aims to streamline plant breeding, improve trial accuracy, and reduce chemical inputs in agricultural research and practice.

iMvalv

Seed Round in 2019
iMvalv is a medical device company based in Santa Fe, Argentina, specializing in innovative solutions for glaucoma management. The company has developed a microvalve that regulates intraocular pressure in glaucoma patients through an implanted chip. This biocompatible device is designed to be compact and energy-efficient, offering telemetric control for precise treatment. By preventing the complications associated with glaucoma, such as optic nerve damage and vision loss, iMvalv aims to enhance the quality of care for patients suffering from this condition.

Nectras

Seed Round in 2017
Nectras is an Argentine company that specializes in agricultural technology, focusing on pest monitoring and control. It has developed an integrated system that utilizes electronic sensors and drones to detect and evaluate pest outbreaks in crops. The company operates a cloud-based software platform that processes data from field traps, providing real-time insights into pest activity. This information allows farmers to efficiently deploy drones for targeted application of agrochemicals, reducing costs associated with traditional pest control methods. By optimizing pest management practices, Nectras helps agricultural producers increase crop yields while minimizing environmental impact.

Phylumtech

Seed Round in 2015
Phylumtech S.A. is a company based in Sunchales, Argentina, specializing in drug discovery solutions. Founded in 2009, it offers innovative products such as WMicroTracker-One, which automatically quantifies the behavior of small animals in microtiter plates, and WMicroTracker Arena, designed to track the movement of individual or groups of animals with enhanced accuracy and resolution. Phylumtech's platform aims to optimize processes and reduce costs in drug development, providing researchers, laboratories, and the pharmaceutical industry with fast, reliable, and high-quality results in the discovery of new molecules.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.